Practical approach to the management of chronic pain

Comprehensive Therapy

Volumn 31, Issue 1, 2005, Pages 40-49

  Marcus, Dawn A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADALIMUMAB; AMITRIPTYLINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; CAPSAICIN; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GABAPENTIN; HYDROXYCHLOROQUINE; INFLIXIMAB; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LIDOCAINE; METHOTREXATE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; PROPRANOLOL; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SALAZOSULFAPYRIDINE; TIZANIDINE; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID; VERAPAMIL;

CHRONIC PAIN; CLINICAL TRIAL; DIGESTIVE SYSTEM FUNCTION DISORDER; GENDER; GROUPS BY AGE; HEADACHE; HUMAN; HYPERTENSION; KIDNEY INJURY; KIDNEY PAPILLA NECROSIS; MEDICAL PRACTICE; MIGRAINE; MYOFASCIAL PAIN; NEUROPATHIC PAIN; PATHOGENESIS; PRACTICE GUIDELINE; REVIEW; RISK FACTOR; SOCIAL PSYCHOLOGY;

EID: 26244452944     PISSN: 00988243     EISSN: None     Source Type: Journal    
DOI: 10.1385/comp:31:1:040     Document Type: Review

References (70)

1. Mantyselka P, Kumpusalo E, Ahonen R, et al. Pain as a reason to visit the doctor: a study in a Finnish primary health care. Pain 2001;89:175-180.
2. Hasselström J, Liu-Palmgren J, Rasjö-Wrååk G. Prevalence of pain in general practice. Eur J Pain 2002;6:375-385.
3. Guereje O, von Korff M, Simon GE, Gater R. Persistent pain and well-being: a World Health Organization study in primary care. JAMA 1998;280:147-151.
4. Blyth FM, March LM, Nicholas MK, Cousins MJ. Chronic pain, work performance and litigation. Pain 2003;103:41-47.
5. Potter M, Schafer S, Gonzalez-Mendez E, et al. Opioids for chronic nonmalignant pain. Attitudes and practices of primary care physicians in the UCSF/Stanford Collaborative Research Network. J Fam Pract 2001;50:145-151.
6. Carey TS, Garrett JM, Jackman A, Hadler N. Recurrence and care seeking after acute back pain: results of a long-term follow-up study. North Carolina Back Pain Project. Med Care 1999;37:157-164.
7. Croft PR, Macfarlane GJ, Papageogiou AC, et al. Outcome of low back pain in general practice: a prospective study. BMJ 1998;316:1356-1359.
8. Thomas E, Silman AJ, Croft PR, et al. Predicting who develops chronic low back pain in primary care: a prospective study. BMJ 1999;318:1662-1667.
9. Schiotz-Christensen B, Nielsen GL, Hansen VK, et al. Long-term prognosis of acute back pain in patients seen in general practice: a 1-year prospective follow-up study. Fam Pract 1999;16:223-232.
10. Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988;33:87-107.
11. Seltzer Z, Dubner R, Shir Y. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain 1990;43:205-218.
12. Guilbaud G, Gautron M, Jazat F, et al. Time course of degeneration and regeneration of myelinated nerve fibers following chronic loose ligatures of the rat sciatic nerve: can nerve lesions be linked to the abnormal pain-related behaviours? Pain 1993;53:147-158.
13. Behbehani MM, Dollberg-Stolik O. Partial sciatic nerve ligation results in an enlargement of the receptive field and enhancement of the response of dorsal horn neurons to noxious stimulation by an adenosine agonist. Pain 1994;58:421-428.
14. Thomas E, Silman AJ, Croft PR, et al. Predictors of early improvement in low back pain in primary care: a prospective study. BMJ 1999;318:1662-1667.
15. Macfarlane GJ, Thomas E, Croft PR, et al. Predictors of early improvement in low back pain amongst consulters to general practice: the influence of premorbid and episode-related factors. Pain 1999;80:113-119.
16. Reis S, Hermoni D, Borkan JM. A new look at low back pain complaints in primary care: a RAMBAM Israeli Family Practice Research Network study. J Fam Pract 1999;48:299-303.
17. Croft PR, Papageogiou AC, Ferry S, et al. Psychological distress and low back pain. Evidence from a prospective study in the general population. Spine 1995;20:2731-2737.
18. Scott SC, Goldberg MS, Mayo NE, Stock SR, Poitras B. The association between cigarette smoking and back pain in adults. Spine 1999;24:1090-1098.
19. Palmer KT, Syddall H, Cooper C, Coggon D. Smoking and musculoskeletal disorders: findings from a British national survey. Ann Rheum Dis 2003;62:33-36.
20. Velly AM, Gornitsky M, Philippe P. Contributing factors to chronic myofascial pain: a case-control study. Pain 2003;104:491-499.
21. Leighton DJ, Reilly T. Epidemiological aspects of back pain: the incidence and prevalence of back pain in nurses compared to the general population. Occup Med (Lond) 1995;45:263-267.
22. Ihlebaek C, Eriksen HR, Ursin H. Prevalence of subjective health complaints (SHC) in Norway. Scand J Public Health 2002;30:20-29.
23. Shootsky SA, Jaeger B, Oye RK. Prevalence of myofascial pain in general internal medicine practice. West J Med 1989;151:157-160.
24. Simons DG, Travell JG, Simons LS. Myofascial Pain and Dysfunction: The Trigger Point Manual, vol. 1. 2nd edn. Lippincott Williams & Wilkins, Baltimore, 1999.
25. Reginster JY. The prevalence and burden of arthritis. Rheumatology 2002;41(Suppl 1):3-6.
26. Steiner G, Smolen J. Autoantibodies in rheumatoid arthritis and their clinical significance. Arthritis Res 2002;4(Suppl 2):S1-S5.
27. Hasselström J, Liu-Palmgren J, Rasjö-Wrååk G. Prevalence of pain in general practice. Eur J Pain 2002;6:375-385.
28. Boreau F, Doubrére J, Luu M. Study of verbal description in neuropathic pain. Pain 1990;42:145-152.
29. Brett KM, Burt CW. Utilization of ambulatory medical care by women: United States, 1997-98. Vital Health Stat 2001;13:1-46.
30. Marcus DA. Gender differences in treatment-seeking chronic headache sufferers. Headache 2001;41:698-703.
31. Ramirez-Lassepas M, Espinosa CE, Cicero JJ, et al. Predictors of intracranial pathological findings in patients who seek emergency care because of headache. Arch Neurol 1997;54:1506-1509.
32. Hasse LA, Ritchey N, Smith R. Predicting the number of headache visits by type of patient seen in family practice. Headache 2002;42:738-746.
33. Tepper S, Dahlöf CH, Dowson A, et al. Prevalence and diagnosis of migraine in a patients consulting their physician with a complaint of headache: data from the Landmark Study. Headache 2004;44:856-864.
34. Cady RK, Schreiber CP. Sinus headache or migraine?: considerations in making a differential diagnosis. Neurology 2002;58(9 Suppl 6):S10-S14.
35. Schreiber CP, Hutchinson S, Webster CJ, et al. Prevalence of migraine in patients with a history of self-reported or physician-diagnosed "sinus" headache. Arch Intern Med 2004;164:1769-1772.
36. Campo JV, Comer DM, Jansen-McWilliams L, Gardner W, Kelleher KJ. Recurrent pain, emotional distress, and health service use in childhood. J Pediatr 2002;141:76-83.
37. De Inocencio J. Musculoskeletal pain in primary pediatric care: analysis of 1000 consecutive general pediatric clinic visits. Pediatrics 1998;102:e63.
38. Ozge A, Bugdayci R, Sasmaz T, et al. The sensitivity and specificity of the case definition criteria in diagnosis of headache: a school-based epidemiological study of 5562 children in Mersin. Cephalalgia 2003;23:138-145.
39. Walker LS, Lipani TA, Greene JW, et al. Recurrent abdominal pain: symptom subtypes based on the Rome II criteria for pediatric functional gastrointestinal disorders. J Ped Gastroenterol Nutr 2004;38:187-191.
40. Mikkelsson M, Salminen JJ, Kautiainen H. Non-specific musculoskeletal pain in preadolescents. Prevalence and 1-year persistence. Pain 1997;73:29-35.
41. Eriksen J, Jensen MK, Sjøgren P, Ekholm O, Rasmussen NK. Epidemiology of chronic non-malignant pain in Denmark. Pain 2003;106:221-228.
42. Royal M, Wieniecke G, Movva V, et al. (223) retrospective study of efficacy of tizanidine in the treatment of chronic pain. Pain Med 2001;2:249.
43. Gam AN, Warming S, Larsen LH, et al. Treatment of myofascial trigger-points with ultrasound combined with massage and exercise - a randomized controlled trial. Pain 1998;77:73-79.
44. Suomi R, Collier D. Effects of arthritis exercise programs on functional fitness and perceived activities of daily living measures in older adults with arthritis. Arch Phys Med Rehabil 2003;84:1589-1594.
45. De Jong Z, Munneke M, Zwinderman AH, et al. Is a long-term high-intensity exercise program effective and safe in patients with rheumatoid arthritis? Arthritis Rheum 2003;48:2415-2424.
46. Munneke M, de Jong Z, Zwinderman AH, et al. Adherence and satisfaction of rheumatoid arthritis patients with a long-term intensive dynamic exercise program (RAPIT Program). Arthritis Care Res 2003;49:665-672.
47. Roddy E, Zhang W, Doherty M, et al. Evidence-based recommendations for the role of exercise in the management of osteoarthritis of the hip or knee - the MOVE consensus. Rheumatology (Oxford) 2005;44: 67-73.
48. Evers AW, Kraaimaat FW, van Riel PL, de Jong AJ. Tailored cognitive-behavioral therapy in early rheumatoid arthritis for patients at risk: a randomized controlled trial. Pain 2002;100:141-153.
49. Sharpe L, Sensky T, Timberlake N, Ryan B, Brewin CR, Allard S. A blind, randomized, controlled trial of cognitive-behavioral intervention for patients with recent onset rheumatoid arthritis: preventing psychological and physical morbidity. Pain 2001;89:275-283.
50. Keefe FJ, Blumenthal J, Baucom D, et al. Effects of spouse-assisted coping skills training and exercise training in patients with osteoarthritic knee pain: a randomized controlled study. Pain 2004;110:539-549.
51. Blumenauer B, Cranney A, Clinch J, Tugwell P. Quality of life in patients with rheumatoid arthritis: which drugs make a difference? Pharmacoeconomics 2003;21:927-940.
52. Sokka T, Möttönen T, Hannonen P. Disease-modifying anti-rheumatic drug use according to the "sawtooth" treatment strategy improves the functional outcome in rheumatoid arthritis: results of a long-term follow-up study with review of the literature. Rheumatology 2000;39:34-42.
53. Osiri M, Shea B, Robinson V, et al. Leflunomide for treating rheumatoid arthritis. Cochrane Database Syst Rev 2003;1:CD002047.
54. Krishnan AM, Rayman G. New treatment for diabetic-neuropathy: symptomatic treatments. Curr Diabet Rep 2003;3:459-467.
55. Dallocchio C, Buffa C, Mazzarello P, Chiroli S. Gabapentin vs. amitriptyline in painful diabetic neuropathy: an open-label pilot study. J Pain Symptom Manage 2000;20:280-285.
56. Marcus DA. Nonpharmacologic treatment of migraine. Trends in Evidence-based Neuropsychiatry 2001;3:50-55.
57. Holroyd KA, Cordingley GE, Pingel JD, et al. Enhancing the effectiveness of abortive therapy: a controlled evaluation of self-management. Headache 1989;29:148-153.
58. Holroyd KA, France JC, Cordingley GE. Enhancing the effectiveness of relaxation-thermal biofeedback training with propranolol hydrochloride. J Consult Clin Psychol 1995;63:327-330.
59. Richards SM, Scott DL. Prescribed exercise in people with fibromyalgia: parallel group randomised controlled trial. BMJ 2002;325:185-189.
60. Friedman DP. Perspectives on the medical use of drugs of abuse. J Pain Symptom Manage 1990;5 (Suppl):S2-S5.
61. Shannon CN, Baranowski AP. Use of opioids in non-cancer pain. Br J Hosp Med 1997;5:459-463.
62. Savage SR. Opioid use in the management of chronic pain. Med Clin North Am 1999;83:761-786.
63. Simon LS, Weaver AL, Graham DY, et al. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis. A randomized controlled trial. JAMA 1999;282:1921-1928.
64. Segasothy M, Chin GL, Sia KK, et al. Chronic nephrotoxicity of anti-inflammatory drugs used in the treatment of arthritis. Br J Rheumatol 1995;34:162-165.
65. Segasothy M, Samad SA, Zulfigar A, Bennett WM. Chronic renal disease and papillary necrosis associated with the long-term use of nonsteroidal anti-inflammatory drugs as the sole or predominant analgesic. Am J Kidney Dis 1994;24:17-24.
66. LeLorier J, Bombardier C, Burgess E, et al. Practical considerations for the use of nonsteroidal anti-inflammatory drugs and cyclo-oxygenase-2 inhibitors in hypertension and kidney disease. Can J Cardiol 2002;18:1301-1308.
67. Deider J, Stampfer MJ, Hankison SE, Willett WC, Speizer FE, Curhan GC. Nonnarcotic analgesic use and risk of hypertension in US women. Hypertension 2002;40:604-608.
68. Reid MC, Engles-Horton LL, Weber MB, Kerns RD, Rogers EL, O'Connor PG. Use of opioid medications for chronic noncancer pain syndromes in primary care. J Gen Intern Med 2002;17:173-179.
69. Chabal C, Erjavec MK, Jacobson L, et al. Prescription opiate abuse in chronic pain patients: clinical criteria, incidence, and predictors. Clin J Pain 1997;13:150-155.
70. Ossipov MH, Lai J, Vanderah TW, Porreca F. Induction of pain facilitation by sustained opioid exposure: relationship to opioid antinociceptive tolerance. Life Sci 2003;73:783-800.